Log in

NASDAQ:BOLT - BioLight Life Sciences Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bolt Technology Corporation consists of four operating units, such as Bolt Technology Corporation (Bolt), A-G Geophysical Products, Inc. (A-G), Real Time Systems Inc. (RTS) and SeaBotix Inc. (SBX). Each of these operating units is reported as a separate reportable segment for all periods presented in the Consolidated Financial Statements. The Company operates in four segments: seismic energy sources reportable segment (Bolt), underwater cables and connectors reportable segment (A-G), seismic energy source controllers reportable segment (RTS) and underwater robotic vehicles segment (SBX). The Company's Bolt, A-G and RTS products are used in marine seismic exploration surveys to acquire seismic data. Bolt develops, manufactures and sells marine seismic energy sources (air guns) and replacement parts. A-G develops, manufactures and sells underwater cables, connectors, hydrophones, depth and pressure transducers and seismic source monitoring systems.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryOil & Gas Equipment & Services
SectorN/A
Current SymbolNASDAQ:BOLT
CUSIP09769810
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive BOLT News and Ratings via Email

Sign-up to receive the latest news and ratings for BOLT and its competitors with MarketBeat's FREE daily newsletter.


BioLight Life Sciences (NASDAQ:BOLT) Frequently Asked Questions

What is BioLight Life Sciences' stock symbol?

BioLight Life Sciences trades on the NASDAQ under the ticker symbol "BOLT."

How were BioLight Life Sciences' earnings last quarter?

BioLight Life Sciences Ltd. (NASDAQ:BOLT) announced its earnings results on Thursday, October, 23rd. The company reported ($0.07) EPS for the quarter. The company earned $11.90 million during the quarter, compared to analyst estimates of $16.20 million. View BioLight Life Sciences' Earnings History.

Has BioLight Life Sciences been receiving favorable news coverage?

News headlines about BOLT stock have been trending very negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. BioLight Life Sciences earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for BioLight Life Sciences.

Who are some of BioLight Life Sciences' key competitors?

What other stocks do shareholders of BioLight Life Sciences own?

When did BioLight Life Sciences IPO?

(BOLT) raised $12 million in an initial public offering on the week of March 14th 2016. The company issued 2,100,000 shares at a price of $4.60-$6.60 per share. Feltl and Company and Rodman & Renshaw a unit of H.C. Wainwright & Co. served as the underwriters for the IPO.

How do I buy shares of BioLight Life Sciences?

Shares of BOLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.


MarketBeat Community Rating for BioLight Life Sciences (NASDAQ BOLT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  51 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  97
MarketBeat's community ratings are surveys of what our community members think about BioLight Life Sciences and other stocks. Vote "Outperform" if you believe BOLT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BOLT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: Balance Sheet

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel